Together, it is possible.

Lung Health

Improving Lung Cancer care for a better tomorrow

We aspire to transform Lung Cancer from a deadly disease to a managed condition where patients have what matters most: more quality time. We know that a unified approach will get us there, because we are Engineering the extraordinary.

Contact Medtronic Watch Video

Lung cancer facts

Lung cancer continues to be a worldwide problem with more people dying of the disease than prostate, breast and colon cancers combined.¹ At present, the majority of new lung cancer cases are recognized at a late stage, which limits treatment options and can significantly reduce the opportunity to improve patient survical.²

This has a life-threatening consequence for patients and a potential crisis for health systems; innovative and cost-efficient solutions must be found to help diagnose patients quicker, so they can receive earlier the treatment that works best for them.

85% of lung cancer cases are caused by smoking.³

74% of lung cancer cases are diagnosed at a late stage.^4,5

25% of all cancer deaths globally are linked to tobacco use.³

Lung cancer is the most commonly diagnosed cancer (11.6 % of the total cases) and the leading cause of cancer death (18.4 % of the total cancer deaths).⁶

12.6% is the 5 year survival rates for lung cancer.⁷

Medtronic is committed to support earlier detection and treatment of lung cancer to improve its 5 year survival rate

5 year survival could increase above 70% if lung cancer is detected earlier.⁸

Medtronic is committed to improve patient outcomes through innovative solutions.

Achieving earlier diagnosis

Together we can further optimize health outcomes through early diagnosis and early recovery, combining innovative technologies and comprehensive medical education programmes for all healthcare providers involved in patient care.

Improving survival sates & quality of life

Together we can refine patients' journey through the care continuum enabling them to get deeper understanding and better preparation.

Optimizing cost efficiency

Together we can offer solutions that streamline the patient pathway and optimize the care continuum through enhancing partnerships that combine managed services, consultative expertise and innovative technology.

References:

1. Lung Cancer Survival Rates | 5-Year Survival Rates for Lung Cancer [Internet]. Cancer.org. 2021 [cited 22 October 2021]. Available from: https://www.cancer.org/cancer/lung-cancer/detection-diagnosis-staging/survival-rates.html

2. How quickly does lung cancer spread? Your FAQs [Internet]. Medicalnewstoday.com. 2021 [cited 22 October 2021]. Available from: https://www.medicalnewstoday.com/articles/how-fast-lung-cancer-spreads

3. Tobacco use causes almost one third of cancer deaths in the WHO European Region Feb 2020. https://www.euro.who.int/en/ health-topics/disease-prevention/tobacco/news/news/2020/2/tobacco-use-causes-almost-one-third-of-cancer-deaths-inthe- who-european-region

4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8. PMID: 31912902.

5. Gildea TR, DaCosta Byfield S, Hogarth DK, Wilson DS, Quinn CC. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. Clinicoecon Outcomes Res. 2017 May 12;9:261-269. doi: 10.2147/CEOR.S132259. PMID: 28553128; PMCID: PMC544003

6. Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394-424.

7. Lung cancer - ERS [Internet]. Erswhitebook.org. 2021 [cited 22 October 2021]. Available from: https://www.erswhitebook.org/chapters/lung-cancer/

8. Blandin Knight Sean, Crosbie Phil A., Balata Haval, Chudziak Jakub, Hussell Tracy and Dive Caroline 2017Progress and prospects of early detection in lung cancerOpen Biol.7170070170070 http://doi.org/10.1098/rsob.170070

9. European commission. Question and answers: A new EU approach to cancer screening, Sep 2022 https://ec.europa.eu/commission/presscorner/detail/en/qanda_22_5584

10. European Lung Foundation. Lung cancer screening. Feb 2024 https://europeanlung.org/en/information-hub/lung-tests-and-procedures/lung-cancer-screening/#:~:text=Smoking%20is%20by%20far%20the,to%20smoke%20and%20have%20quit

11. G. Veronesi. Early Detection and Early treatment of lung cancer: risks and benefi ts, Journal of Thoracic Disease 2016 Sept 8 (9) E1060-1062. 12 H. de Koenig Nelson Trial. CT screening reduces Lung Cancer Mortality, Sept 2018.

12. H. de Koning Nelson Trial. CT screening reduces Lung Cancer Mortality in a Randomized Trial. N Engl J Med 2020; 382:503-513. February 6, 2020.

13. World Health Organization, Guide to cancer early diagnosis. 2017. ISBN 978-92-4-151194-0

14. D. Dziedzic. The Role of VATS in Lung Cancer Surgery, current status and prospects for development, Minim Invasive Surgery July 2015 :938430:

15. Pocket guide to COPD diagnosis, management and prevention. 2017 Global Initiative for Chronic Obstructive Lung Disease, Inc. Cleveland Clinic.

16. Lee M, Sharma S, Mora Carpio AL. Lung Volume Reduction Surgery. [Updated 2024 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559329/ Accessed September 2024

17. Whittaker H.R. et al., Eligibility for Lung Volume Reduction Surgery in Patients With COPD Identified in a UK Primary Care Setting. 157#2 CHEST FEBRUARY 2020

18. Gerard J. et al National Emphysema Treatment Trial The Major Outcomes of Lung Volume Reduction Surgery in Severe Emphysema. Temple University School of Medicine, Philadelphia, Pennsylvania; and Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland. Proceedings of the American Thoracic society, Vol. 5 2008

YOU ARE ENTERING HCP CONTENT ONLY